ArticleJournal of neuroinflammation2026

Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism.

Maria Luque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.